These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 12389082

  • 1. Opposite effects of testosterone and estrogens on chronic allograft nephropathy.
    Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U.
    Transpl Int; 2002 Oct; 15(9-10):494-501. PubMed ID: 12389082
    [Abstract] [Full Text] [Related]

  • 2. Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats.
    Antus B, Liu S, Yao Y, Zou H, Song E, Lutz J, Heemann U.
    Nephrol Dial Transplant; 2005 Feb; 20(2):329-35. PubMed ID: 15618244
    [Abstract] [Full Text] [Related]

  • 3. The involvement of activated T cells and growth-factor production in the early and late phase of chronic kidney allograft nephropathy in rats.
    Hamar P, Szabó A, Müller V, Heemann U.
    Transpl Int; 2002 Oct; 15(9-10):446-54. PubMed ID: 12389075
    [Abstract] [Full Text] [Related]

  • 4. Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone.
    Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U.
    Kidney Int; 2001 Nov; 60(5):1955-63. PubMed ID: 11703615
    [Abstract] [Full Text] [Related]

  • 5. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I, Khan ZA, Lian D, Jiang J, Zhong R, Garcia B, Chakrabarti S.
    Transplantation; 2006 Aug 15; 82(3):406-14. PubMed ID: 16906041
    [Abstract] [Full Text] [Related]

  • 7. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J, Rintala J, von Willebrand E.
    Transplant Proc; 2006 Dec 15; 38(10):3231-2. PubMed ID: 17175231
    [Abstract] [Full Text] [Related]

  • 8. Sex hormones and gender-related differences: their influence on chronic renal allograft rejection.
    Müller V, Szabó A, Viklicky O, Gaul I, Pörtl S, Philipp T, Heemann UW.
    Kidney Int; 1999 May 15; 55(5):2011-20. PubMed ID: 10231466
    [Abstract] [Full Text] [Related]

  • 9. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
    Lutz J, Huang H, Deng M, Wagner B, Roos M, Schmaderer C, Strobl M, Heemann U.
    Transplantation; 2007 Mar 27; 83(6):741-6. PubMed ID: 17414707
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ.
    J Surg Res; 2009 Nov 27; 157(1):e117-27. PubMed ID: 19589538
    [Abstract] [Full Text] [Related]

  • 11. Early application of Met-RANTES ameliorates chronic allograft nephropathy.
    Song E, Zou H, Yao Y, Proudfoot A, Antus B, Liu S, Jens L, Heemann U.
    Kidney Int; 2002 Feb 27; 61(2):676-85. PubMed ID: 11849411
    [Abstract] [Full Text] [Related]

  • 12. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M, Liu S, Strobl M, Schmaderer C, Baumann M, Heemann U, Lutz J.
    Transplant Proc; 2008 Dec 27; 40(10):3731-6. PubMed ID: 19100477
    [Abstract] [Full Text] [Related]

  • 13. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Oct 27; 38(8):2719-21. PubMed ID: 17098049
    [Abstract] [Full Text] [Related]

  • 14. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH.
    Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186
    [Abstract] [Full Text] [Related]

  • 15. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J, Taskinen E, Von Willebrand E.
    Transplantation; 2003 Apr 27; 75(8):1147-53. PubMed ID: 12717194
    [Abstract] [Full Text] [Related]

  • 16. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Nephrol Dial Transplant; 2008 Nov 27; 23(11):3446-55. PubMed ID: 18558624
    [Abstract] [Full Text] [Related]

  • 17. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
    Ma X, Lu YP, Yang L, Song J, Luo GH, Shi YJ, Li YP.
    Transplant Proc; 2008 Oct 27; 40(8):2795-9. PubMed ID: 18929864
    [Abstract] [Full Text] [Related]

  • 18. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM, Savikko J, Rintala SE, von Willebrand E.
    Transplant Proc; 2006 Dec 27; 38(10):3239-40. PubMed ID: 17175234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R, Lu Y, Xin YP, Zhang XH, Wang J, Li YP.
    Transplant Proc; 2006 Sep 27; 38(7):2154-7. PubMed ID: 16980029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.